Crosslinking and Fulguration in the Treatment of Acanthamoebic Keratitis
Open Access
- 27 December 2020
- journal article
- Published by PE Polunina Elizareta Gennadievna in Ophthalmology in Russia
- Vol. 17 (4), 725-732
- https://doi.org/10.18008/1816-5095-2020-4-725-732
Abstract
Purpose: to study the combined Photo-Activated Chromophore for Keratitis — Corneal Cross-Linking (PACK-CXL) in combination with fulguration of the infiltration zone in the treatment of medically refractive acanthamoebic keratitis.Patients and methods. The study included 9 patients (10 eyes) with medically refractive acanthamoebic keratitis. The diagnosis was confirmed by confocal microscopy data from a microbiological study of scraping of corneal tissue from the lesion site with Romanovsky-Giemsa stain. All patients underwent combined surgical treatment of PACK-CXL with pre-fulguration. Optical coherence tomography (OCT) of the anterior segment of the eye was also performed using an RTVue-100 apparatus (Optovue USA), determination of visual acuity, photographing before and after surgery.Results. In 6 cases (60 %), a positive effect was noted, relief of the symptoms of the disease and the formation of turbidity within a month after the procedure, as well as an increase in the maximum corrected visual acuity. According in vivo confocal microscopy, 6 months after the intervention, no signs of infection were detected. In 4 cases, the therapeutic effect was absent. Subsequently, 3 patients (3 eyes) underwent therapeutic keratoplasty. In one eye, the infectious process was stopped medically for 6 months.Conclusion. The combined PACK-CXL method together with fulguration can be effective and safe in the treatment of medically refractive acanthamoebic keratitis, allowing keratoplasty to be performed with an optical goal if necessary, after stopping the infection process in a distant period.Keywords
This publication has 16 references indexed in Scilit:
- PACK-CXL: Defining CXL for Infectious KeratitisJournal of Refractive Surgery, 2014
- Corneal collagen cross-linking using riboflavin and ultraviolet-A irradiation: a review of clinical and experimental studiesInternational Ophthalmology, 2011
- Ultraviolet-a light and riboflavin therapy for acanthamoeba keratitis: a case report.Case Reports in Ophthalmology, 2011
- Riboflavin and Ultraviolet Light A Therapy as an Adjuvant Treatment for Medically Refractive Acanthamoeba Keratitis: Report of 3 CasesOphthalmology, 2011
- Pathogen Reduction Technology Treatment of Platelets, Plasma and Whole Blood Using Riboflavin and UV LightTransfusion Medicine and Hemotherapy, 2011
- Safety and efficacy of collagen crosslinking for the treatment of keratoconusExpert Opinion on Drug Safety, 2010
- Ultraviolet A/Riboflavin Corneal Cross-linking for Infectious Keratitis Associated With Corneal MeltsCornea, 2008
- Toxicity Testing of a Novel Riboflavin-Based Technology for Pathogen Reduction and White Blood Cell InactivationTransfusion Medicine Reviews, 2008
- Riboflavin/ultraviolet-a–induced collagen crosslinking for the treatment of keratoconusAmerican Journal of Ophthalmology, 2003
- Photosensitized inactivation of ribonucleic acids in the presence of riboflavinBiochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis, 1965